Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03409614
Brief Title: Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

First Submitted : January 10, 2018
First Submitted that Met QC Criteria : January 23, 2018
First Posted : January 24, 2018

Last Update Submitted that Met QC Criteria : October 7, 2020
Last Update Posted : October 8, 2020